On January 3, 2025, Harpreet Grewal, a Director at Penumbra Inc (PEN, Financial), sold 167 shares of the company. Following this transaction, the insider now owns 8,530 shares of Penumbra Inc. The details of this transaction can be found in the SEC Filing.
Penumbra Inc is a global healthcare company focused on innovative therapies. The company designs, develops, manufactures, and markets medical devices for use by healthcare professionals. Its products are used to treat a wide range of conditions, including vascular and neurovascular diseases.
Over the past year, Harpreet Grewal has sold a total of 1,115 shares and has not purchased any shares. The insider transaction history for Penumbra Inc indicates that there have been 0 insider buys and 27 insider sells over the same period.
On the day of the recent sale, shares of Penumbra Inc were trading at $241.28, giving the stock a market cap of $9.988 billion. The company's price-earnings ratio stands at 302.63, which is higher than the industry median of 27.65 but lower than the company’s historical median price-earnings ratio.
With a trading price of $241.28 and a GF Value of $282.54, Penumbra Inc has a price-to-GF-Value ratio of 0.85, indicating that the stock is fairly valued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated using historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
